| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |